(April 20, 2018, 1:55 PM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on April 19 said 11 fellow district court judges volunteered to try 20 bellwether trials involving AbbVie Inc.’s AndroGel between Oct. 2 and March 4 (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.)....